Engineered Antibodies Fight Bacteria, May Stave Off Antibiotic Resistance (1 of 4) (IMAGE)

American Association for the Advancement of Science (AAAS)

Engineered Antibodies Fight Bacteria, May Stave Off Antibiotic Resistance (1 of 4)

Caption

An antibody is disrupting the Pseudomonas aeruginosa injectisome. One of three mechanisms for MEDI3902 is its ability to bind and disrupt the bacterium's ability to inject toxins into human cells by binding and disrupting the needle like injectisome on the surface of the bacterium. This image relates to a paper that appeared in the Nov. 12, 2014, issue of Science Translational Medicine, published by AAAS. The paper, by Dr. A. DiGiandomenico at MedImmune, LLC in Gaithersburg, Md., and colleagues was titled, "A multifunctional bispecific antibody protects against Pseudomonas aeruginosa."

Credit

MedImmune LLC

Usage Restrictions

Please cite the owner of the material when publishing. This material may be freely used by reporters as part of news coverage, with proper attribution. Non-reporters must contact <i>Science</i> for permission.

License

Licensed content

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.